Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$12,109,420
+$1,731,668 QoQ
Shares Held
48,122
+0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#818
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NAPLES GLOBAL ADVISORS, LLC holds $87,787,212 across 12 Drug Manufacturers - General names. ABBV ranks #5 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,798 | $15,350,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
106,535 | $13,689,747 | |
| 3 | JNJ |
Johnson & Johnson
|
52,184 | $13,253,170 | |
| 4 | AMGN |
Amgen Inc
|
35,170 | $12,735,760 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
48,122 | $12,109,420 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
89,358 | $5,148,807 | |
| 7 | AZN |
Astrazeneca PLC
|
24,721 | $4,687,596 | |
| 8 | NVS |
Novartis AG
|
26,087 | $4,088,354 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,109,420 | 48,122 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $10,377,752 | 47,716 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $10,911,768 | 47,756 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $11,191,948 | 48,337 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $8,774,071 | 47,269 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $9,981,113 | 47,638 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $8,666,962 | 48,773 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $9,665,066 | 48,942 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $8,472,744 | 49,398 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,019,413 | 49,530 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $7,764,926 | 50,106 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $7,689,111 | 51,584 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $7,046,513 | 52,301 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $8,385,890 | 52,619 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $8,559,673 | 52,965 | Shares | Sole | 2023-04-17 | |
| 2022-09-30 | $7,149,098 | 53,268 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $8,051,621 | 52,570 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,370,711 | 51,636 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $7,004,377 | 51,731 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $5,535,996 | 51,321 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $5,549,547 | 49,268 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $5,083,959 | 46,978 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,926,757 | 45,980 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,794,661 | 43,323 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,171,766 | 42,491 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $3,151,827 | 41,368 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||